Related Experiment Videos
Protective immunity to amebiasis: new insights and new challenges
1Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, USA. sstanley@im.wustl.edu
The Journal of Infectious Diseases
|July 27, 2001
Summary
Immunity to amebiasis (E. histolytica infection) can develop in children, offering resistance to reinfection. However, this protective immunity appears short-lived, highlighting the need for further research.
Area of Science:
- Infectious Diseases
- Immunology
- Parasitology
Background:
- Amebiasis, caused by Entamoeba histolytica, is a significant parasitic disease and a leading cause of death.
- Understanding protective immunity against amebiasis is crucial but remains limited.
Purpose of the Study:
- To investigate the development and duration of protective immunity following intestinal amebiasis in a cohort of children.
- To identify potential correlates of protection against Entamoeba histolytica reinfection.
Main Methods:
- A longitudinal study of children in Bangladesh was conducted.
- Mucosal IgA antibody levels against the amebic adherence lectin were measured.
- Rates of Entamoeba histolytica reinfection were monitored.
Main Results:
- Children with mucosal IgA antibodies to the amebic adherence lectin showed resistance to reinfection.
- Approximately 20% of children experienced a second episode of infection, indicating transient immunity.
- The presence of protective immunity was observed, but its duration was limited.
Conclusions:
- Immunity to intestinal amebiasis can be acquired in children after infection.
- Protective immunity against Entamoeba histolytica may be transient.
- Further studies are needed to establish the role of this immunity in preventing amebiasis disease.